Clinical Trial Update: Study of CM310 Injection in Adolescent Subjects With Atopic Dermatis [Phase 3]

View source ↗

Summary

Phase 3 trial of CM310 injection in adolescents with atopic dermatitis has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Atopic Dermatitis

Drugs mentioned

• CM310

Snippet

Sponsor: Keymed Biosciences Co.Ltd | Conditions: Atopic Dermatitis | Phase 3 | Status: COMPLETED